These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7525810)

  • 1. [Basic facts and clinical application of hematopoietic factors].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):482-6. PubMed ID: 7525810
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
    Greenberg PL
    Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
    Ganser A; Hoelzer D
    Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hast R; Bernell P
    Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 6. [The strategy for the treatment of myelodysplastic syndromes].
    Hideaki M
    Rinsho Ketsueki; 2002 Mar; 43(3):157-60. PubMed ID: 11979745
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in the research of clinical use of recombinant human granulocyte colony-stimulating factors].
    Jiang FG; Geng JP; Yang CL
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):723-5. PubMed ID: 1726145
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
    Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
    [No Abstract]   [Full Text] [Related]  

  • 9. Indications and guidelines for the use of hematopoietic growth factors.
    Goodnough LT; Anderson KC; Kurtz S; Lane TA; Pisciotto PT; Sayers MH; Silberstein LE
    Transfusion; 1993; 33(11):944-59. PubMed ID: 7505068
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes.
    Della Porta MG
    Leuk Res; 2011 Jan; 35(1):22-3. PubMed ID: 20727588
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
    Ganser A; Hoelzer D
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of G-CSF in hematological disorders].
    Dan K
    Rinsho Ketsueki; 1997 May; 38(5):367-70. PubMed ID: 9194376
    [No Abstract]   [Full Text] [Related]  

  • 14. A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.
    Croockewit AJ; Bronchud MH; Aapro MS; Bargetzi MJ; Crown J; Gratwohl A; Lange W; Ludwig H; Martinelli G; Mertelsmann R; Nuessler V; Willemze R; De Witte TJ; Zittoun R; Zwierzina H
    Eur J Cancer; 1997 Oct; 33(11):1732-46. PubMed ID: 9470826
    [No Abstract]   [Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone?
    Musto P; Falcone A; Carotenuto M; Catalano L; Cennamo A; Rotoli B
    Blood; 1994 Sep; 84(5):1687-8. PubMed ID: 7520783
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aplastic anemia successfully treated with erythropoietin and rhG-CSF].
    Higashino K; Kito K; Hodohara K; Fujiyama Y; Banba T; Hosoda S
    Rinsho Ketsueki; 1992 Sep; 33(9):1237-41. PubMed ID: 1279235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematopoietic factors: cytokine].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):368-72. PubMed ID: 7525808
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1994; 15():367-90. PubMed ID: 7540031
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.
    Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.